Boston Children’s Hospital Study Reveals Surge in Antibiotic Resistance Risks for Medically Complex Pediatric Patients

Study reveals children with multiple chronic conditions face 6x higher antibiotic rates, sparking calls for urgent stewardship to fight resistance.

By: AXL Media

Published: Apr 24, 2026, 3:30 AM EDT

Rising Prescription Rates Linked to Medical Complexity

A national analysis of Medicaid-enrolled children has uncovered a direct, non-linear correlation between a child’s underlying medical complexity and their frequency of antibiotic use. Presented by Dr. Kathleen D. Snow at the Pediatric Academic Societies 2026 Meeting, the research highlights that while roughly one-third of all Medicaid-enrolled children filled an antibiotic prescription in 2023, those with three or more complex chronic conditions experienced markedly higher exposure. The annual fill rate for the most complex patients reached 2,882 per 1,000 persons, a stark contrast to the 514 per 1,000 persons recorded for healthy children.

The Dangerous Shift Toward Broad-Spectrum Agents

The study identified a troubling shift in the types of medications prescribed as medical complexity increases. For healthy children, traditional antibiotics like penicillins, cephalosporins, and macrolides constitute 93% of all prescriptions. However, for children managing three or more complex conditions, these common drugs represent only 64% of their intake. This population is significantly more likely to be prescribed sulfonamides, quinolones, and aminoglycosides, drug classes often reserved for more resistant infections but which carry less favorable safety profiles and higher risks for systemic complications.

A Domino Effect for Global Antibiotic Resistance

The implications of these findings extend beyond individual patient health, feeding into the broader global threat of antimicrobial resistance. Because children with medical complexity (CMC) are inherently more vulnerable to frequent infections, they become frequent users of the healthcare system’s strongest defensive tools. Dr. Snow noted that these children now represent the highest annual prescription rate of any population group, pediatric or adult. This intense exposure creates a biological pressure cooker where bacteria are more likely to develop resistance, potentially rendering standard treatments ineffective for future infections.